Medications

Is long-term beta-blocker therapy needed after a heart attack?

The cardiovascular safety of an interrupting beta-blocker could not be shown in comparison to continuation in patients with a history of myocardial infarction (MI) and there was no benefit to the patients' quality of life, ...

Cardiology

Study identifies aortic valve gradient as key to TAVR outcomes

Patients with a combination of left ventricular dysfunction and low aortic valve gradient, or reduced force of blood flow through the aortic valve, have higher mortality rates and a greater risk of recurrent heart failure ...

Cardiology

LVEF improvement for many with primary prevention ICDs

(HealthDay)—Forty percent of patients with primary prevention implantable cardioverter-defibrillators (ICDs) experience improvement in left ventricular ejection fraction (LVEF), according to a study published in the Aug. ...

page 1 from 3